Washington, D.C. 20549


FORM 12b-25


Commission File No. 000-55369




(Check One):

☐   Form 10-K

☐   Form 20-F 

☐   Form 11-K

☒   Form 10-Q

☐   Form 10-D

☐   Form N-SAR

☐   Form N-CSR


For Period Ended: January 31, 2021


Transition Report on Form 10-K

Transition Report on Form 20-F

Transition Report on Form 11-K

Transition Report on Form 10-Q

Transition Report on Form N-SAR

For the Transition Period Ended: __________________


If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:




Huaizhong Health Group, Inc.

Full Name of Registrant



Former Name if Applicable


Tianan Technology Park

13/F Headquarters Center Building 16

555 Panyu North Ave., Panyu District

Address of Principal Executive Office (Street and Number)

Guangzhou City, China

City, State and Zip Code





PART II — RULES 12b-25(b) AND (c)


If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)



The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;



The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and



The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.




State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report thereof, could not be filed within the prescribed time period.


Huaizhong Health Group, Inc. (the "Company") could not complete the filing of its Quarterly Report on Form 10-Q for the period ended January 31, 2021 due to a delay in obtaining and compiling information required to be included in the Company's Form 10-Q, which delay could not be eliminated by the Company without unreasonable effort and expense. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company will file its Form 10-Q no later than the fifth calendar day following the prescribed due date.





Name and telephone number of person to contact in regard to this notification


Yuantong Wang

+86 (20)

2982 9356


(Area Code)

(Telephone Number)



Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

Yes ☒   No ☐


Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

Yes ☐   No ☒

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.






Huaizhong Health Group, Inc.

(Name of Registrant as Specified in Charter)


has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.


Date: March 23, 2021


/s/ Yuantong Wang


Name: Yuantong Wang


Title: President






Huaizhong Health (PK) (USOTC:ADAD)
Historical Stock Chart
From Jul 2021 to Aug 2021 Click Here for more Huaizhong Health (PK) Charts.
Huaizhong Health (PK) (USOTC:ADAD)
Historical Stock Chart
From Aug 2020 to Aug 2021 Click Here for more Huaizhong Health (PK) Charts.